Literature DB >> 27858808

Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals From the Neurocritical Care Society and the Society of Critical Care Medicine.

Jennifer A Frontera1, John J Lewin, Alejandro A Rabinstein, Imo P Aisiku, Anne W Alexandrov, Aaron M Cook, Gregory J Del Zoppo, Monisha Kumar, Ellinor I B Peerschke, Michael F Stiefel, Jeanne S Teitelbaum, Katja E Wartenberg, Cindy L Zerfoss.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27858808     DOI: 10.1097/CCM.0000000000002057

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  18 in total

Review 1.  Safety and efficacy of prothrombin complex concentrate (PCC) for anticoagulation reversal in patients undergoing urgent neurosurgical procedures: a systematic review and metaanalysis.

Authors:  Harrison Faulkner; Shubham Chakankar; Marco Mammi; Jack Yu Tung Lo; Joanne Doucette; Nawaf Al-Otaibi; Judi Abboud; Andrew Le; Rania A Mekary; Adomas Bunevicius
Journal:  Neurosurg Rev       Date:  2020-10-03       Impact factor: 3.042

2.  Management of Complications in Anticoagulated Patients with Atrial Fibrillation.

Authors:  George D Katritsis; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-12

3.  Head injury in the elderly - an overview for the physician.

Authors:  William Beedham; George Peck; Simon E Richardson; Kevin Tsang; Michael Fertleman; David Jh Shipway
Journal:  Clin Med (Lond)       Date:  2019-03       Impact factor: 2.659

4.  Incidence of thrombotic complications related to weight-based dosing of activated prothrombin complex concentrate (aPCC) for reversal of apixaban and rivaroxaban in obese patients.

Authors:  Caitlyn Whitaker; Amanda McKinney; Reagan Bollig; Nathan Hieb; R Frank Roberts; A Shaun Rowe
Journal:  J Thromb Thrombolysis       Date:  2021-11-17       Impact factor: 5.221

Review 5.  Management of Subdural Hematomas: Part I. Medical Management of Subdural Hematomas.

Authors:  Elena I Fomchenko; Emily J Gilmore; Charles C Matouk; Jason L Gerrard; Kevin N Sheth
Journal:  Curr Treat Options Neurol       Date:  2018-06-23       Impact factor: 3.598

Review 6.  Resumption of Anticoagulation After Intracranial Hemorrhage.

Authors:  Ivan Rocha Ferreira da Silva; Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2017-09-30       Impact factor: 3.598

7.  Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage.

Authors:  Jennifer A Frontera; Prachi Bhatt; Rebecca Lalchan; Shadi Yaghi; Tania Ahuja; John Papadopoulos; Danielle Joset
Journal:  J Thromb Thrombolysis       Date:  2020-01       Impact factor: 2.300

Review 8.  Treating the body to prevent brain injury: lessons learned from the coronavirus disease 2019 pandemic.

Authors:  Tracey H Fan; Veronika Solnicky; Sung-Min Cho
Journal:  Curr Opin Crit Care       Date:  2022-04-01       Impact factor: 3.687

Review 9.  [Clinical presentation of bleeding in critically ill patients in the intensive care unit : Organ systems and clinical implications].

Authors:  Andreas Drolz; Valentin Fuhrmann
Journal:  Med Klin Intensivmed Notfmed       Date:  2021-08-24       Impact factor: 0.840

10.  Investigation of the Optimal Dose aPCC in Reversing the Effect of Factor Xa Inhibitors-An In Vitro Study.

Authors:  Nina Haagenrud Schultz; Jawed Fareed; Pål Andre Holme
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.